Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of...
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the...
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads